GPT and cancer: In vivo treatments with AOA, an inhibitor of PLP‐dependent transaminases (e.g., ALT, GOT), is effective in reducing cancer growth through the inhibition of the glutamine‐glutamate utilization pathway (Qing et al, 2012; Korangath et al, 2015).